(Sharecast News) - 4basebio appointed Richard Bungay as chief financial officer on Thursday, as the synthetic DNA specialist prepares for what it described as a phase of accelerated commercial growth.
The AIM-listed company said Bungay would take up the role in July, succeeding David Roth, who stepped down from the board...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE